BIOTISSUE's CryoTek Method: Mechanism of Action

Show Description +

BIOTISSUE's proprietary CryoTek processing method preserves the active extracellular matrix (ECM) components of the amniotic membrane, including heavy chain hyaluronic acid, PTX 3 [HC-HA activator], collagens (types I, III, IV, V, and VI), fibronectin, laminin, proteoglycans, and growth factors. BIOTISSUE's CryoTek products retain key components responsible for regenerative wound healing.

Posted: 12/17/2012

Keywords:

Bio-Tissue

Cornea

Corneal Disease

BIOTISSUE's CryoTek Method: Mechanism of Action

BIOTISSUE's proprietary CryoTek processing method preserves the active extracellular matrix (ECM) components of the amniotic membrane, including heavy chain hyaluronic acid, PTX 3 [HC-HA activator], collagens (types I, III, IV, V, and VI), fibronectin, laminin, proteoglycans, and growth factors. BIOTISSUE's CryoTek products retain key components responsible for regenerative wound healing.

Posted: 12/17/2012

Keywords:

Bio-Tissue

Cornea

Corneal Disease

Please log in to leave a comment.